Blood‑based biomarkers offer a real opportunity to improve dementia care – but only if we redesign our systems to use them ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results